Table 1 Demographic and clinical characteristics of newly identified HCV antibody positive patients, UCLA Health system, November 2015–September 2017
HCV Antibody Positivea (n = 320) | ||
|---|---|---|
n | % | |
Age group (years) | ||
18–52 | 99 | 31.4 |
52–72 (“Baby Boomers”) | 198 | 61.5 |
≥ 73 | 23 | 7.1 |
Sex | ||
Male | 179 | 55.9 |
Female | 140 | 44.1 |
Race/Ethnicity | ||
Asian or Pacific Islander | 5 | 1.8 |
Black or African American | 38 | 13.4 |
Hispanic or Latino | 25 | 8.8 |
Otherb | 33 | 11.6 |
White or Caucasian | 183 | 64.4 |
Clinical Characteristics | ||
Hepatitis C RNA detected | 135 | 42 |
HIV Positive | 10 | 3.1 |
Chronic Kidney Diseasec | 23 | 7.2 |
Diabetes Mellitus | 45 | 14.2 |
Laboratory Results d | ||
ALT (U/L) | 25 (17–47) | |
AST(U/L) | 26 (20–39) | |
Platelet count | 232 (188–271) | |
Bilirubin (mg/dL) | 0.5 (0.3–0.7) | |